preview

Science Behind Electroporation, Its Applications, And Explore Some Of The Companies Developing Treatments

Better Essays

On October 24th, 2016 Inovio Pharmaceuticals (INO) announced the FDA had placed a hold on its proposed Phase 3 trial for its electroporation system CELLECTRA, being tested in combintion with immunotherapy treatment VGX-3100, over concerns about the product’s shelf life. Generally speaking, this delay has sparked greater investor interest in electroporation immunotherapy and the pharmaceutical companies (NASDAQ:INO, NYSE:PFE, VTX:ROG, and private company Ichor) working to advance the technology. This week we will overview what investors need to know about the science behind electroporation, its applications, and explore some of the companies developing treatments. What is Electroporation? Electroporation is a microbiology method in which an electrical field is applied to cells in order to make their membrane more permeable. This permeability allows for much greater cellular uptake of chemicals, drugs, and DNA and could allow for significant improvements in treating a wide range of diseases with targeted electrical currents. There are currently 4 main types of electroporation: Irreversible (IRE), Non Thermal Irreversible (N-TIRE), High frequency irreversible (H-FIRE), and as a drug/DNA immunotherapy delivery method. The first three are used to destroy cells directly while the last is used to deliver chemical agents to treat disease. IRE uses high voltage electroporation to irreversibly destroy targeted cells within a narrow range without damaging nearby cells. IRE is

Get Access